Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed a citation regarding a study on Ruxolitinib for COVID-19 treatment, which included an erratum reference.
    Difference
    0.2%
    Check dated 2025-05-08T07:19:38.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T04:00:38.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed descriptions of a clinical study on ruxolitinib for COVID-19, while retaining the study's identifier and collaborator information.
    Difference
    16%
    Check dated 2025-04-16T14:32:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:26:32.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:27:56.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T20:42:44.000Z thumbnail image

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.